Incentive Spirometry in Routine Management of COPD Patients
Value of Incentive Spirometry in Routine Management of COPD Patients and Its Effect on Diaphragmatic Function
1 other identifier
interventional
40
1 country
1
Brief Summary
The incentive spirometer is a device that encourages patients, with visual and other positive feedback, to maximally inflate their lungs and sustain that inflation. However, its efficacy in patients with COPD has been little documented especially in diaphragmatic function. This study tried to assess the role of incentive spirometry on Spirometric functions, Sonographic diaphragmatic function, and the scale of dyspnea in COPD patients with exacerbation and with follow-up of these parameters after 2 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2022
CompletedFirst Submitted
Initial submission to the registry
December 16, 2022
CompletedFirst Posted
Study publicly available on registry
January 11, 2023
CompletedJanuary 11, 2023
December 1, 2022
1.2 years
December 16, 2022
December 23, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
assessing the change in baseline diaphragmatic excursion in cm
assessing the change from Baseline diaphragmatic excursion (in cm) using ultrasound to 2 months
2 months
assessing the change in baseline percentage of diaphragmatic thickness fraction
assessing the change from baseline percentage of diaphragmatic thickness fraction (%) using ultrasound to 2 months
2 months
assessing the change in baseline forced vital capacity percentage of predicted
assessing the change from baseline forced vital capacity percentage of predicted (%) using spirometry to 2 months
2 months
assessing the change in baseline forced expiratory volume in 1st second/forced vital capacity percentage (%)
assessing the change from baseline forced expiratory volume in 1st second/forced vital capacity percentage (%) using spirometry to 2 months
2 months
assessing the change in baseline peak expiratory flow rate percentage
assessing the change from baseline peak expiratory flow rate percentage (%) using spirometry to 2 months
2 months
change in arterial blood gases
assessment the change in baseline PaO2 and PaCO2 (in mmHg) to 2 months
2 months
assessing the change in mMRC dysnea scale
assessing the change in the severity of dyspnea by mMRC dysnea scale from baseline to 2 months. It is 5 statements giving grades from 0 to 4 with the higher the degree, the more severe the shortness of breath in patients with COPD
2 months
Study Arms (2)
group 1
EXPERIMENTALparticipants would use incentive spirometry for 2 months together with ordinary medical treatment
group 2
NO INTERVENTIONparticipants would receive only ordinary medical treatment for 2 months
Interventions
It is flow-oriented that has 3 chambers, (600, 900, and 1200 cc/s) and it has a mouthpiece and a ball in each chamber. After a quiet exhalation, each participant was instructed to take slow full inspirations and to keep as long as he can for at least 5 seconds, then he slowly expires. The device is used every hour at least 5 to 10 times in the session during wake time.
Eligibility Criteria
You may qualify if:
- confirmed cases of COPD according to the criteria GOLD
- age more than 40 years
You may not qualify if:
- bad acoustic window by ultrasound
- other chronic respiratory diseases
- lung malignancy
- recent major surgery
- inability to complete or perform the study
- patient refusal
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Amal A. El-Koa
Cairo, Egypt
Related Publications (10)
GBD Chronic Respiratory Disease Collaborators. Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Respir Med. 2020 Jun;8(6):585-596. doi: 10.1016/S2213-2600(20)30105-3.
PMID: 32526187BACKGROUNDScherer TA, Spengler CM, Owassapian D, Imhof E, Boutellier U. Respiratory muscle endurance training in chronic obstructive pulmonary disease: impact on exercise capacity, dyspnea, and quality of life. Am J Respir Crit Care Med. 2000 Nov;162(5):1709-14. doi: 10.1164/ajrccm.162.5.9912026.
PMID: 11069801BACKGROUNDPetrovic M, Reiter M, Zipko H, Pohl W, Wanke T. Effects of inspiratory muscle training on dynamic hyperinflation in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2012;7:797-805. doi: 10.2147/COPD.S23784. Epub 2012 Nov 30.
PMID: 23233798BACKGROUNDBarakat S, Michele G, George P, Nicole V, Guy A. Outpatient pulmonary rehabilitation in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2008;3(1):155-62. doi: 10.2147/copd.s2126.
PMID: 18488439BACKGROUNDCortopassi F, Castro AA, Porto EF, Colucci M, Fonseca G, Torre-Bouscoulet L, Iamonti V, Jardim JR. Comprehensive exercise training improves ventilatory muscle function and reduces dyspnea perception in patients with COPD. Monaldi Arch Chest Dis. 2009 Sep;71(3):106-12. doi: 10.4081/monaldi.2009.355.
PMID: 19999956BACKGROUNDStock MC, Downs JB, Gauer PK, Alster JM, Imrey PB. Prevention of postoperative pulmonary complications with CPAP, incentive spirometry, and conservative therapy. Chest. 1985 Feb;87(2):151-7. doi: 10.1378/chest.87.2.151.
PMID: 3881226BACKGROUNDAARC (American Association for Respiratory Care) clinical practice guideline. Incentive spirometry. Respir Care. 1991 Dec;36(12):1402-5. No abstract available.
PMID: 10145589BACKGROUNDCasaburi R, Porszasz J, Burns MR, Carithers ER, Chang RS, Cooper CB. Physiologic benefits of exercise training in rehabilitation of patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1997 May;155(5):1541-51. doi: 10.1164/ajrccm.155.5.9154855.
PMID: 9154855BACKGROUNDDarnley GM, Gray AC, McClure SJ, Neary P, Petrie M, McMurray JJ, MacFarlane NG. Effects of resistive breathing on exercise capacity and diaphragm function in patients with ischaemic heart disease. Eur J Heart Fail. 1999 Aug;1(3):297-300. doi: 10.1016/s1388-9842(99)00027-6.
PMID: 10935679BACKGROUNDCheng YY, Lin SY, Hsu CY, Fu PK. Respiratory Muscle Training Can Improve Cognition, Lung Function, and Diaphragmatic Thickness Fraction in Male and Non-Obese Patients with Chronic Obstructive Pulmonary Disease: A Prospective Study. J Pers Med. 2022 Mar 16;12(3):475. doi: 10.3390/jpm12030475.
PMID: 35330474BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- doctor
Study Record Dates
First Submitted
December 16, 2022
First Posted
January 11, 2023
Study Start
March 1, 2021
Primary Completion
May 1, 2022
Study Completion
July 1, 2022
Last Updated
January 11, 2023
Record last verified: 2022-12